Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

PHASQ

PhaseBio Pharmaceuticals (CE) (PHASQ)

PhaseBio Pharmaceuticals Inc (CE)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:PHASQ
일자시간출처헤드라인심볼기업
2024/05/1705:32Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2024/05/1705:28Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/11/3006:55Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/11/1606:17Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/10/0320:17Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/09/2721:52Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/08/2601:34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/08/2601:31Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/07/0105:21Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/05/3105:03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/05/2005:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/05/2005:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/05/2005:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/05/2005:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/05/1705:23Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/04/0405:06Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/03/2421:08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/02/1507:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/02/1505:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2023/02/1504:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2022/12/2322:34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2022/12/2120:10Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2022/12/0306:20Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2022/11/1606:21Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
2022/11/0505:44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
 검색 관련기사 보기:USOTC:PHASQ